Abs-9 (SPAC5H10.01) is a fully human IgG1 antibody derived from memory B cells of volunteers immunized with a recombinant five-component S. aureus vaccine (rFSAV). It was selected from 676 antigen-binding clonotypes for its high affinity and prophylactic efficacy against drug-resistant S. aureus strains .
Abs-9 binds to the α-helix region of SpA5, disrupting S. aureus immune evasion mechanisms. Structural modeling (AlphaFold2 and molecular docking) revealed the antibody-antigen complex involves hydrophobic and electrostatic interactions, with key residues E848, E849, and R851 mediating binding .
Mouse Sepsis Model:
The epitope (N847-S857) was validated via:
ELISA: KLH-conjugated peptide (N847-S857) showed strong binding to Abs-9.
Competitive Binding: Synthetic peptide inhibited Abs-9 binding to SpA5 by 70–80% .
SPAC5H10.01 is a protein found in Schizosaccharomyces pombe (strain 972/ATCC 24843), commonly known as fission yeast. It is identified by UniProt accession number Q09674. This protein is studied as part of understanding fundamental cellular processes in S. pombe, which serves as an important model organism for eukaryotic cell biology. The protein's function may relate to cellular processes that are conserved across eukaryotes, making it valuable for comparative genomics and evolutionary studies. Antibodies against this protein allow researchers to track its expression, localization, and interactions within the cell .
The SPAC5H10.01 Antibody is primarily used in fundamental research applications including:
Western blotting for protein expression analysis
Immunohistochemistry (IHC) for localization studies
Immunoprecipitation (IP) for protein-protein interaction studies
Flow cytometry for quantitative analysis of protein expression in cell populations
Immunofluorescence microscopy for subcellular localization
Similar antibodies in research settings typically require optimization for each specific application, as seen with other research antibodies like HO-1 monoclonal antibody, which is recommended for flow cytometry, ICC, IHC, and Western blotting applications .
While specific storage information for SPAC5H10.01 Antibody isn't explicitly stated in the available search results, best practices based on similar research antibodies suggest:
Long-term storage: -20°C to -70°C
Short-term storage: 2-8°C under sterile conditions after reconstitution
Avoid repeated freeze-thaw cycles by aliquoting the antibody upon receipt
For comparison, similar antibodies like Human PU.1/Spi-1 Antibody recommend storage at -20 to -70°C for 12 months from receipt date, 2-8°C for 1 month under sterile conditions after reconstitution, or -20 to -70°C for 6 months under sterile conditions after reconstitution .
Optimization of antibody dilutions should follow a systematic approach:
Start with the manufacturer's recommended dilution range
Perform a dilution series experiment (typically 1:500, 1:1000, 1:2000, 1:5000)
Include appropriate positive and negative controls
Assess signal-to-noise ratio for each dilution
For Western blotting applications, similar antibodies are typically used at dilutions around 1:1000 with ECL detection systems. For example, HO-1 monoclonal antibody is recommended at 1:1,000 dilution for Western blot with ECL detection . For flow cytometry, a starting concentration of 10μg/ml may be appropriate, based on similar antibody recommendations. Remember that optimal conditions must be determined individually for each application and sample type .
A robust experimental design with appropriate controls is essential for antibody-based experiments:
| Control Type | Purpose | Implementation |
|---|---|---|
| Positive Control | Confirms antibody works | Sample known to express SPAC5H10.01 |
| Negative Control | Assesses non-specific binding | Sample known to not express SPAC5H10.01 |
| Isotype Control | Evaluates background | Same species/isotype as primary antibody but non-targeting |
| Secondary-only Control | Checks secondary antibody specificity | Omit primary antibody |
| Blocking Peptide Control | Confirms epitope specificity | Pre-incubate antibody with immunizing peptide |
Similar approaches are used with other research antibodies, as seen in the detection of PU.1/Spi-1 in THP-1 cells by flow cytometry, where researchers used an isotype control antibody (Catalog # MAB004) alongside the target antibody .
While specific protocols for SPAC5H10.01 Antibody are not available in the search results, a general immunoprecipitation protocol for yeast proteins would include:
Prepare yeast cell lysate under non-denaturing conditions
Lyse cells in buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 0.5% NP-40, and protease inhibitors
Homogenize using glass beads and vortexing in cycles of 30 seconds on/30 seconds off
Centrifuge at 14,000×g for 10 minutes at 4°C to remove debris
Pre-clear lysate with protein A/G beads for 1 hour at 4°C
Incubate pre-cleared lysate with SPAC5H10.01 Antibody (2-5μg per 500μg total protein) overnight at 4°C with gentle rotation
Add protein A/G beads and incubate for 2-4 hours at 4°C
Wash beads 4-5 times with IP buffer
Elute bound proteins by boiling in SDS sample buffer
Analyze by SDS-PAGE followed by Western blotting
This approach is similar to methods used for other antibody-antigen interactions in research settings, such as the approach used to confirm Abs-9 antibody specificity for SpA5 antigen .
Weak or non-specific banding can result from several factors:
Antibody concentration: Too low concentration can result in weak signal; increase antibody concentration incrementally.
Protein expression level: SPAC5H10.01 may be expressed at low levels; increase total protein loaded or use enrichment techniques.
Detection system sensitivity: Switch to more sensitive detection systems like enhanced chemiluminescence (ECL).
Cross-reactivity: Non-specific bands may indicate cross-reactivity with similar epitopes; try more stringent washing or different blocking agents.
Protein degradation: Additional bands may represent degradation products; add more protease inhibitors during sample preparation.
For comparison, similar approaches are used when analyzing Western blot results for other antibodies, as demonstrated with Human PU.1/Spi-1 Antibody, where specific bands were detected at approximately 40 kDa when used with K562 human chronic myelogenous leukemia cell line and Daudi human Burkitt's lymphoma cell line .
Verifying antibody specificity is critical for ensuring reliable research results:
Knockout/knockdown validation:
Use CRISPR/Cas9 to generate SPAC5H10.01 knockout strains
Compare antibody signal between wild-type and knockout samples
Loss of signal in knockout confirms specificity
Mass spectrometry validation:
Perform immunoprecipitation with SPAC5H10.01 Antibody
Analyze precipitated proteins by mass spectrometry
Confirm that SPAC5H10.01 is the predominant protein identified
Epitope blocking:
Pre-incubate antibody with excess immunizing peptide
Apply to samples in parallel with unblocked antibody
Specific signal should be reduced or eliminated in blocked samples
Multiple antibody validation:
Use a second antibody targeting a different epitope of SPAC5H10.01
Compare localization or expression patterns
Concordant results increase confidence in specificity
This multi-faceted approach to validation is similar to methods used for other research antibodies, such as those described for the Abs-9 antibody against SpA5, where researchers used mass spectrometry to confirm specific binding after immunoprecipitation .
Accurate quantification of protein levels requires careful attention to methodology:
Western blot densitometry:
Ensure linear range of detection (avoid saturated signals)
Normalize to loading controls (e.g., actin, GAPDH, or total protein stain)
Use at least three biological replicates
Apply appropriate statistical analysis
Flow cytometry quantification:
Use appropriate isotype controls to set negative populations
Report mean fluorescence intensity (MFI) or percent positive cells
Consider using quantitative beads for absolute quantification
Image-based quantification:
Maintain consistent acquisition settings across all samples
Use automated analysis software to reduce bias
Measure integrated intensity within defined regions of interest
Normalize to cell area or number
For example, similar approaches in flow cytometry are used for other antibodies, such as in the detection of PU.1/Spi-1 in THP-1 human acute monocytic leukemia cell line, where cells were stained with the target antibody and compared to an isotype control, with results presented as histogram distributions .
Co-localization studies provide valuable insights into protein-protein interactions and functional relationships:
Dual immunofluorescence staining:
Use SPAC5H10.01 Antibody in combination with antibodies against other yeast proteins
Choose primary antibodies from different host species to avoid cross-reactivity
Use species-specific secondary antibodies with distinct fluorophores
Apply appropriate controls to validate staining specificity
Proximity ligation assay (PLA):
Use SPAC5H10.01 Antibody and antibody against potential interaction partner
Apply species-specific PLA probes
Perform ligation and rolling circle amplification
Visualize interaction points as distinct fluorescent spots
Quantitative co-localization analysis:
Calculate Pearson's correlation coefficient or Mander's overlap coefficient
Use ImageJ with co-localization plugins for automated analysis
Report both visual and statistical measures of co-localization
This approach is conceptually similar to methods used in other antibody-based research, such as the identification and characterization of antibodies against S. aureus, where multiple experimental techniques were combined to fully characterize antibody-antigen interactions .
Studying protein dynamics during the cell cycle requires special experimental considerations:
Synchronization methods for S. pombe:
Nitrogen starvation and release
Hydroxyurea block and release
Temperature-sensitive cdc mutants
Select method based on specific cell cycle phase of interest
Time-course experimental design:
Collect samples at defined intervals after synchronization
Verify synchronization by flow cytometry or microscopy
Process all samples identically to ensure comparability
Quantification approaches:
Western blotting with densitometry for total protein levels
Immunofluorescence for spatial distribution changes
Fractionation studies for compartmental localization shifts
Considerations for data interpretation:
Account for cell cycle-dependent changes in reference proteins
Use multiple synchronization methods to confirm findings
Consider population heterogeneity in analyses
These approaches align with best practices in cell biology research and can be adapted based on specific research questions related to SPAC5H10.01 function during the S. pombe cell cycle.
Integrating antibody-based techniques with proteomics offers powerful research opportunities:
Immunoprecipitation coupled to mass spectrometry (IP-MS):
Use SPAC5H10.01 Antibody to pull down protein complexes
Identify interacting partners through mass spectrometry
Compare interaction networks under different conditions
Proximity-dependent biotin identification (BioID):
Create fusion protein of SPAC5H10.01 with BioID enzyme
Validate fusion protein expression/localization with SPAC5H10.01 Antibody
Identify proteins in close proximity through streptavidin pull-down and MS
Cross-linking mass spectrometry (XL-MS):
Chemically cross-link protein complexes in vivo
Immunoprecipitate SPAC5H10.01-containing complexes
Identify cross-linked peptides to map interaction interfaces
This integration of antibody-based techniques with advanced proteomics is similar to approaches used in other research contexts, such as the identification of human antibodies against S. aureus through high-throughput single-cell RNA and VDJ sequencing combined with downstream characterization .
While specific information about SPAC5H10.01's role in stress response is not detailed in the search results, researchers can design experiments to investigate this question:
Stress induction experiments:
Expose S. pombe cells to various stressors (oxidative, heat, osmotic)
Use SPAC5H10.01 Antibody to track protein expression changes
Compare with known stress response markers
Genetic interaction studies:
Create double mutants with known stress response genes
Assess synthetic phenotypes under stress conditions
Use SPAC5H10.01 Antibody to monitor protein levels in different genetic backgrounds
Phosphorylation state analysis:
Immunoprecipitate SPAC5H10.01 under normal and stress conditions
Perform phospho-specific Western blotting or mass spectrometry
Identify potential regulatory modifications in response to stress
This approach to investigating protein function in stress response pathways represents a standard methodology in molecular and cellular biology research, allowing for systematic characterization of protein function across different conditions.